Multiple sclerosis in childhood: Clinical and radiological features

Journal of Child Neurology

Volumn 24, Issue 1, 2009, Pages 56-62

  Forrester, Michael B ^a   Coleman, Lee ^a,b   Kornberg, Andrew J ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Acute disseminated encephalomyelitis; ADEM; Early onset multiple sclerosis; Glatiramer; Interferon; MRI; MS; Outcome

Indexed keywords

BETA1A INTERFERON; GADOLINIUM; GLATIRAMER; INTERFERON BETA SERINE; OLIGOCLONAL BAND;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DEMYELINATION; DISEASE COURSE; FAMILY HISTORY; FEMALE; FINGER MALFORMATION; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; INJECTION SITE BURNING; MALE; MULTIPLE SCLEROSIS; OPTIC NEURITIS; PRIORITY JOURNAL; PYRAMIDAL SIGN; RELAPSE; RETROSPECTIVE STUDY;

ADOLESCENT; BRAIN; CHILD; DEMYELINATING DISEASES; ENCEPHALOMYELITIS; FEMALE; HUMANS; IMMUNOTHERAPY; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 59349089523     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073808321042     Document Type: Article

References (40)

1. Boiko A., Vorobeychik G., Paty D., Devonshire V., Sadovnick D. Early onset multiple sclerosis: A longitudinal study. Neurology. 2002; 59(7): 1006-1010.
2. Simone IL, Carrara D., Tortorella C., et al. Course and prognosis in early-onset MS: Comparison with adult-onset forms. Neurology. 2002; 59(12): 1922-1928.
3. Duquette P., Murray TJ, Pleines J., et al. Multiple sclerosis in childhood: Clinical profile in 125 patients. J Pediatr. 1987; 111(3): 359-363.
4. Gall JC Jr., Hayles AB, Siekert RG, Keith HM Multiple sclerosis in children; a clinical study of 40 cases with onset in childhood. Pediatrics. 1958; 21(5): 703-709.
5. Ghezzi A., Pozzilli C., Liguori M., et al. Prospective study of multiple sclerosis with early onset. Mult Scler. 2002; 8(2): 115-118.
6. Hynson JL, Kornberg AJ, Coleman LT, Shield L., Harvey AS, Kean MJ Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology. 2001; 56(10): 1308-1312.
7. Kurtzke JF Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology. 1983; 33(11): 1444-1452.
8. Poser CM, Paty DW, Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol. 1983; 13(3): 227-231.
9. Lublin FD, Reingold SC Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996; 46(4): 907-911.
10. McDonald WI, Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001; 50(1): 121-127.
11. Poser CM, Goutieres F., Carpentier MA, Aicardi J. Schilder's myelinoclastic diffuse sclerosis. Pediatrics. 1986; 77(1): 107-112.
12. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999; 53(5): 1107-1114.
13. Sadovnick AD, Baird PA, Ward RH Multiple sclerosis: Updated risks for relatives. Am J Med Genet. 1988; 29(3): 533-541.
14. Ghezzi A., Deplano V., Faroni J., et al. Multiple sclerosis in childhood: Clinical features of 149 cases. Mult Scler. 1997; 3(1): 43-46.
15. Hanefeld F. Characteristics of childhood multiple sclerosis. Int MS J. 1995; 3: 91-98.
16. Selcen D., Anlar B., Renda Y. Multiple sclerosis in childhood: Report of 16 cases. Eur Neurol. 1996; 36(2): 79-84.
17. Johnson KP, Nelson BJ Multiple sclerosis: Diagnostic usefulness of cerebrospinal fluid. Ann Neurol. 1977; 2(5): 425-431.
18. Swanson J. Multiple sclerosis: Update in diagnosis in review of prognostic factors. Mayo Clin Proc. 1989; 64: 577-586.
19. McFarlin DE, McFarland HF Multiple sclerosis (second of two parts). N Engl J Med. 1982; 307(20): 1246-1251.
20. McFarlin DE, McFarland HF Multiple sclerosis (first of two parts). N Engl J Med. 1982; 307(19): 1183-1188.
21. Haslam R. Multiple sclerosis: Experience at the Hospital for Sick Children. Int Pediatr. 1987(2): 163-167.
22. Rust RS Multiple sclerosis, acute disseminated encephalomyelitis, and related conditions. Semin Pediatr Neurol. 2000; 7(2): 66-90.
23. Tenembaum S., Chamoles N., Fejerman N. Acute disseminated encephalomyelitis: A long-term follow-up study of 84 pediatric patients. Neurology. 2002; 59(8): 1224-1231.
24. Ascherio A., Zhang SM, Hernan MA, et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med. 2001; 344(5): 327-332.
25. Dagher AP, Smirniotopoulos J. Tumefactive Demyelinating lesions. Neuroradiology. 1996; 38: 560-565.
26. Tintore M., Rovira A., Rio J., et al. New diagnostic criteria for multiple sclerosis: Application in first demyelinating episode. Neurology. 2003; 60(1): 27-30.
27. Dalton CM, Brex PA, Miszkiel KA, et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol. 2002; 52(1): 47-53.
28. Weinshenker BG, Bass B., Rice GP, et al. The natural history of multiple sclerosis: A geographically based study. I. Clinical course and disability. Brain. 1989; 112(pt 1): 133-146.
29. Fischer JS, Priore RL, Jacobs LD, et al. Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann Neurol. 2000; 48(6): 885-892.
30. MacAllister WS, Belman AL, Milazzo M., et al. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology. 2005; 64(8): 1422-1425.
31. Banwell BL, Anderson PE The cognitive burden of multiple sclerosis in children. Neurology. 2005; 64(5): 891-894.
32. Goodin DS, Frohman EM, Garmany GP Jr, et al. Disease modifying therapies in multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology. 2002; 58(2): 169-178.
33. The IFNB Multiple Sclerosis Study Group UoBCMMAG. Interferon b-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial. Neurology; 45: 1277-1285.
34. The IFNB Multiple Sclerosis Study Group UoBCMMAG. Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology. 1995; 45(7): 1277-1285.
35. Paty DW, Li DK, UBC MS/MRI Study Group, IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology. 1993; 43: 662-667.
36. Mikaeloff Y., Moreau T., Debouverie M., et al. Interferon-beta treatment in patients with childhood-onset multiple sclerosis. J Pediatr. 2001; 139(3): 443-446.
37. Pohl D., Rostasy K., Gartner J., Hanefeld F. Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a. Neurology. 2005; 64(5): 888-890.
38. Banwell B., Tremlett H. Coming of age: The use of immunomodulatory therapy in children with multiple sclerosis. Neurology. 2005; 64(5): 778-779.
39. Rodriguez-Casero MV, Shield LK, Coleman LT, Kornberg AJ Childhood chronic inflammatory demyelinating polyneuropathy with central nervous system demyelination resembling multiple sclerosis. Neuromuscul Disord. 2003; 13(2): 158-161.
40. Vineis P., Crosignani P., Vigano C., et al. Lymphomas and multiple sclerosis in a multicenter case-control study. Epidemiology. 2001; 12(1): 134-135.